These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 20176735

  • 1. Stathmin, a microtubule-destabilizing protein, is dysregulated in spinal muscular atrophy.
    Wen HL, Lin YT, Ting CH, Lin-Chao S, Li H, Hsieh-Li HM.
    Hum Mol Genet; 2010 May 01; 19(9):1766-78. PubMed ID: 20176735
    [Abstract] [Full Text] [Related]

  • 2. Decreased stathmin expression ameliorates neuromuscular defects but fails to prolong survival in a mouse model of spinal muscular atrophy.
    Wen HL, Ting CH, Liu HC, Li H, Lin-Chao S.
    Neurobiol Dis; 2013 Apr 01; 52():94-103. PubMed ID: 23268200
    [Abstract] [Full Text] [Related]

  • 3. Neurodevelopmental consequences of Smn depletion in a mouse model of spinal muscular atrophy.
    Liu H, Shafey D, Moores JN, Kothary R.
    J Neurosci Res; 2010 Jan 01; 88(1):111-22. PubMed ID: 19642194
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Smn deficiency causes neuritogenesis and neurogenesis defects in the retinal neurons of a mouse model of spinal muscular atrophy.
    Liu H, Beauvais A, Baker AN, Tsilfidis C, Kothary R.
    Dev Neurobiol; 2011 Feb 01; 71(2):153-69. PubMed ID: 20862739
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Is spinal muscular atrophy the result of defects in motor neuron processes?
    Briese M, Esmaeili B, Sattelle DB.
    Bioessays; 2005 Sep 01; 27(9):946-57. PubMed ID: 16108074
    [Abstract] [Full Text] [Related]

  • 8. Mitochondrial dysfunction in a neural cell model of spinal muscular atrophy.
    Acsadi G, Lee I, Li X, Khaidakov M, Pecinova A, Parker GC, Hüttemann M.
    J Neurosci Res; 2009 Sep 01; 87(12):2748-56. PubMed ID: 19437551
    [Abstract] [Full Text] [Related]

  • 9. AAV9-Stathmin1 gene delivery improves disease phenotype in an intermediate mouse model of spinal muscular atrophy.
    Villalón E, Kline RA, Smith CE, Lorson ZC, Osman EY, O'Day S, Murray LM, Lorson CL.
    Hum Mol Genet; 2019 Nov 15; 28(22):3742-3754. PubMed ID: 31363739
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Stat5 constitutive activation rescues defects in spinal muscular atrophy.
    Ting CH, Lin CW, Wen SL, Hsieh-Li HM, Li H.
    Hum Mol Genet; 2007 Mar 01; 16(5):499-514. PubMed ID: 17220171
    [Abstract] [Full Text] [Related]

  • 13. Spinal muscular atrophy: going beyond the motor neuron.
    Hamilton G, Gillingwater TH.
    Trends Mol Med; 2013 Jan 01; 19(1):40-50. PubMed ID: 23228902
    [Abstract] [Full Text] [Related]

  • 14. Co-regulation of survival of motor neuron and Bcl-xL expression: implications for neuroprotection in spinal muscular atrophy.
    Anderton RS, Price LL, Turner BJ, Meloni BP, Mitrpant C, Mastaglia FL, Goh C, Wilton SD, Boulos S.
    Neuroscience; 2012 Sep 18; 220():228-36. PubMed ID: 22732506
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Microtubule-associated protein 1B dysregulates microtubule dynamics and neuronal mitochondrial transport in spinal muscular atrophy.
    Bora G, Hensel N, Rademacher S, Koyunoğlu D, Sunguroğlu M, Aksu-Mengeş E, Balcı-Hayta B, Claus P, Erdem-Yurter H.
    Hum Mol Genet; 2021 Feb 25; 29(24):3935-3944. PubMed ID: 33410474
    [Abstract] [Full Text] [Related]

  • 17. Survival motor neuron SMN1 and SMN2 gene promoters: identical sequences and differential expression in neurons and non-neuronal cells.
    Boda B, Mas C, Giudicelli C, Nepote V, Guimiot F, Levacher B, Zvara A, Santha M, LeGall I, Simonneau M.
    Eur J Hum Genet; 2004 Sep 25; 12(9):729-37. PubMed ID: 15162126
    [Abstract] [Full Text] [Related]

  • 18. Synthesis and biological evaluation of novel 2,4-diaminoquinazoline derivatives as SMN2 promoter activators for the potential treatment of spinal muscular atrophy.
    Thurmond J, Butchbach ME, Palomo M, Pease B, Rao M, Bedell L, Keyvan M, Pai G, Mishra R, Haraldsson M, Andresson T, Bragason G, Thosteinsdottir M, Bjornsson JM, Coovert DD, Burghes AH, Gurney ME, Singh J.
    J Med Chem; 2008 Feb 14; 51(3):449-69. PubMed ID: 18205293
    [Abstract] [Full Text] [Related]

  • 19. The SMN binding protein Gemin2 is not involved in motor axon outgrowth.
    McWhorter ML, Boon KL, Horan ES, Burghes AH, Beattie CE.
    Dev Neurobiol; 2008 Feb 01; 68(2):182-94. PubMed ID: 18000835
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.